Taken together, Oncomine and GEPIA databases jointly suggested that the mRNA expression of MT1E, MT1F, MT1G, MT1H, MT1M, MT1X, and MT2A was significantly downregulated in patients with HCC. This evidence concerns the gene MT1H and hepatocellular carcinoma.